1. Result: Both fluoxetine hydrochloride and amitriptyline had a good effect in treatment of depression.

2. P450 2C9 substrates mainly include tolbutamide, phenytoin, S-warfarin, fluoxetine, and losartan.

3. B. Fluoxetine (Sarafem) 20 mg or sertraline (Zoloft) 50 mg, taken in the morning, is best tolerated and sufficient to improve symptoms.

4. ABSTRACT: Objective To determine whether fluoxetine and trazodone could be effective in the treatment of anxiety.

5. Conclusion Fluoxetine can improve depressive symptoms of senile hypertensive patients with depression and have definite hypotensor actions.

6. Therefore, fluoxetine is able to increase the plasma concentrations of imipramine , leading to QT interval prolongation.

7. Conclusions: Early fluoxetine treatment of post - stroke depression is availability in improving PSD.

8. Results:Desipramine and fluoxetine both have the potential to increase the MWT in mice with oxaliplatin-induced neuropathic pain.

9. Objective: To investigate the comparative efficacy of fluoxetine versus trazodone in depression with remarkable retardation and lack of energy.

10. CONCLUSION: The therapeutic effect of fluoxetine hydrochloride was close to that of clomipramine.

11. Conclusions:Both clomipramine and fluoxetine are effective in treatment of child depression with few side effects.

12. The two best-known drugs in the study were fluoxetine, better known as Prozac, and paroxetine, sold in the United States under the name Paxil.

13. CONCLUSION: Fluoxetine in combination with bifid-triple viable capsule can effectively treat irritable bowel syndrome.

14. Antidepressants are most commonly used, including doxepin, amitriptyline, fluoxetine, and clomipramine.

15. CONCLUSION: Fluoxetine combined with maprotiline in the treatment of depression associated with anxiety, as venlafaxine, show equivalent clinical effects with similar adverse reactions.

16. The team of researchers analyzed the ability of fluoxetine to stimulate new bone formation under normal conditions and to block bone loss caused by inflammation or estrogen loss due to ovariectomy.

17. Objective:To evaluate the efficacy and safety of reboxetine versus fluoxetine in the elder patients with depression.

18. Objective To compare the efficacy and side effects of fluoxetine with clomipramine in treating 60 refractory obsessive - compulsive patients.

19. Objective To explore the changes of STAI before and after medication on panic disorder with fluoxetine plus clonazepam.

20. OBJECTIVE:To establish a HPLC-fluorometric method for simultaneous determination of three antidepressants-venlafaxine, fluoxetine and sertraline in human plasma.

21. Methods 30 narcolepsy subjects with cataplexy who had no direct or specific treatment since 6 months were admitted to the department for fluoxetine treatment efficacy studies.

22. The frequency and intensity of yawning began to decrease 5 days after fluoxetine discontinuation.

23. The present study provides the first autoradiographic evidence of age-dependent regional changes in the density of serotonin (5-HT) transporters in offspring following prenatal exposure to fluoxetine.

24. OBJECTIVE : To probe into the current situation and developing trend of Fluoxetine.

25. Objective To study the curative effects and the side effects of Fluoxetine Hydrochloride and Methylphenidate in treatment of attention deficit hyperactivity disorder(ADHD).

26. A 26-year-old man with schizophrenia, disorganised type, and depression, developed severe tardive dyskinesia during treatment with risperidone and fluoxetine.

27. Nor were there significant differences in the risk of suicidal acts within the SSRI drug class in the comparisons among citalopram, fluvoxamine, paroxetine, sertraline, and fluoxetine.

28. DISCUSSION: This adverse drug reaction is thought to be a pharmacodynamic additive effect among fluoxetine, imipramine, and levofloxacin.

29. Objectives : To compare the efficacy and side - effects of fluoxetine hydrochloride and amitriptyline in treatment of depression.

30. Objective To compare the effects and side reactions of fluoxetine and imipramine in treatment of depressive disorders.

31. To evaluate the anti - aggression efficacy of Fluoxetine in antisocial personality disorder subjects.

32. The side reactions in imipramine group was highter than in fluoxetine group.